FDA Announces That Companies Must Stop Marketing Suppository Products Containing Trimethobenzamide (Medical News Today)
As part of the Food and Drug Administration's (FDA) on-going initiative to ensure that all marketed U.S. drugs have required marketing approval, the agency announced today that companies must stop manufacturing and distributing unapproved suppository drug products containing trimethobenzamide hydrochloride. These products are used to treat nausea and vomiting in adults and children. [click link ...

Pharmatech Associates' Quality, Validation and Compliance Solutions Highlighted at INTERPHEX 2007 (Business Wire via Yahoo! Finance)
FOSTER CITY, Calif.----Pharmatech Associates, Inc., a leader in pharmaceutical and biotech manufacturing process methodology, will showcase its complete range of consulting services and publicly launch its new Regulatory Compliance Group at INTERPHEX in New York City, April 24-26, 2007.